Cargando…

In vitro characterization of arylhydrazones of active methylene derivatives

Arylhydrazones of active methylene compounds (AHAMCs) are potent chemotherapy agents for the cancer treatment. AHAMCs enhance the apoptotic cell death and antiproliferation properties in cancer cells. In this study, a series of AHAMCs, 13 compounds, was assayed for cytotoxicity, apoptosis, externali...

Descripción completa

Detalles Bibliográficos
Autores principales: Palanivel, Suresh, Zhurina, Anastasia, Doan, Phuong, Chandraseelan, Jerome G., Khandelwal, Vinoth Kumar Megraj, Zubkov, Fedor I., Mahmudov, Kamran T., Pombeiro, Armando J.L., Yli-Harja, Olli, Kandhavelu, Meenakshisundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856940/
https://www.ncbi.nlm.nih.gov/pubmed/29556135
http://dx.doi.org/10.1016/j.jsps.2017.12.018
_version_ 1783307375185231872
author Palanivel, Suresh
Zhurina, Anastasia
Doan, Phuong
Chandraseelan, Jerome G.
Khandelwal, Vinoth Kumar Megraj
Zubkov, Fedor I.
Mahmudov, Kamran T.
Pombeiro, Armando J.L.
Yli-Harja, Olli
Kandhavelu, Meenakshisundaram
author_facet Palanivel, Suresh
Zhurina, Anastasia
Doan, Phuong
Chandraseelan, Jerome G.
Khandelwal, Vinoth Kumar Megraj
Zubkov, Fedor I.
Mahmudov, Kamran T.
Pombeiro, Armando J.L.
Yli-Harja, Olli
Kandhavelu, Meenakshisundaram
author_sort Palanivel, Suresh
collection PubMed
description Arylhydrazones of active methylene compounds (AHAMCs) are potent chemotherapy agents for the cancer treatment. AHAMCs enhance the apoptotic cell death and antiproliferation properties in cancer cells. In this study, a series of AHAMCs, 13 compounds, was assayed for cytotoxicity, apoptosis, externalization of phosphatidylserine, heterogeneity and cellular calcium level changes. The in vitro cytotoxicity study against HEK293T cells suggests that AHAMCs have significant cytotoxic effect over the concentrations. Top 5 compounds, 5-(2-(2-hydroxyphenyl) hydrazono)pyrimidine-2,4,6(1H,3H,5H)-trione (5), 4-hydroxy-5-(2-(2,4,6-trioxo-tetrahydro-pyrimidin-5(6H) ylidene)hydrazinyl)benzene-1,3-disulfonic acid (6), 5-chloro-3-(2-(4,4-dimethyl-2,6-dioxocyclohexylidene)hydrazinyl)-2-hydroxybenzenesulfonic acid (8), 5-(2-(4,4-dimethyl-2,6-dioxocyclohexylidene)hydrazinyl)-4-hydroxybenzene-1,3-disulfonic acid (9) and 2-(2-sulfophenylhydrazo)malononitrile (10) were chosen for the pharmacodynamics study. Among these, compound 5 exhibited the better cytotoxic effect with the IC(50) of 50.86 ± 2.5 mM. DNA cleavage study revealed that 5 induces cell death through apoptosis and shows more effects after 24 and/or 48 h. Independent validation of apoptosis by following the externalization of phosphatidylserine using Annexin-V is also in agreement with the potential activity of 5. Single cell image analysis of Annexin-V bound cells confirms the presence of mixture of early, mid and late apoptotic cells in the population of the cells treated with 5 and a decreased trend in cell-to-cell variation over the phase was also identified. Additionally, intracellular calcium level measurements identified the Ca(2+) up-regulation in compound treated cells. A brief inspection of the effect of the compound 5 against multiple human brain astrocytoma cells showed a better cell growth inhibitory effect at micro molar level. These systematic studies provide insights in the development of novel AHAMACs compounds as potential cell growth inhibitors for cancer treatment.
format Online
Article
Text
id pubmed-5856940
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-58569402018-03-19 In vitro characterization of arylhydrazones of active methylene derivatives Palanivel, Suresh Zhurina, Anastasia Doan, Phuong Chandraseelan, Jerome G. Khandelwal, Vinoth Kumar Megraj Zubkov, Fedor I. Mahmudov, Kamran T. Pombeiro, Armando J.L. Yli-Harja, Olli Kandhavelu, Meenakshisundaram Saudi Pharm J Article Arylhydrazones of active methylene compounds (AHAMCs) are potent chemotherapy agents for the cancer treatment. AHAMCs enhance the apoptotic cell death and antiproliferation properties in cancer cells. In this study, a series of AHAMCs, 13 compounds, was assayed for cytotoxicity, apoptosis, externalization of phosphatidylserine, heterogeneity and cellular calcium level changes. The in vitro cytotoxicity study against HEK293T cells suggests that AHAMCs have significant cytotoxic effect over the concentrations. Top 5 compounds, 5-(2-(2-hydroxyphenyl) hydrazono)pyrimidine-2,4,6(1H,3H,5H)-trione (5), 4-hydroxy-5-(2-(2,4,6-trioxo-tetrahydro-pyrimidin-5(6H) ylidene)hydrazinyl)benzene-1,3-disulfonic acid (6), 5-chloro-3-(2-(4,4-dimethyl-2,6-dioxocyclohexylidene)hydrazinyl)-2-hydroxybenzenesulfonic acid (8), 5-(2-(4,4-dimethyl-2,6-dioxocyclohexylidene)hydrazinyl)-4-hydroxybenzene-1,3-disulfonic acid (9) and 2-(2-sulfophenylhydrazo)malononitrile (10) were chosen for the pharmacodynamics study. Among these, compound 5 exhibited the better cytotoxic effect with the IC(50) of 50.86 ± 2.5 mM. DNA cleavage study revealed that 5 induces cell death through apoptosis and shows more effects after 24 and/or 48 h. Independent validation of apoptosis by following the externalization of phosphatidylserine using Annexin-V is also in agreement with the potential activity of 5. Single cell image analysis of Annexin-V bound cells confirms the presence of mixture of early, mid and late apoptotic cells in the population of the cells treated with 5 and a decreased trend in cell-to-cell variation over the phase was also identified. Additionally, intracellular calcium level measurements identified the Ca(2+) up-regulation in compound treated cells. A brief inspection of the effect of the compound 5 against multiple human brain astrocytoma cells showed a better cell growth inhibitory effect at micro molar level. These systematic studies provide insights in the development of novel AHAMACs compounds as potential cell growth inhibitors for cancer treatment. Elsevier 2018-03 2018-01-02 /pmc/articles/PMC5856940/ /pubmed/29556135 http://dx.doi.org/10.1016/j.jsps.2017.12.018 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Palanivel, Suresh
Zhurina, Anastasia
Doan, Phuong
Chandraseelan, Jerome G.
Khandelwal, Vinoth Kumar Megraj
Zubkov, Fedor I.
Mahmudov, Kamran T.
Pombeiro, Armando J.L.
Yli-Harja, Olli
Kandhavelu, Meenakshisundaram
In vitro characterization of arylhydrazones of active methylene derivatives
title In vitro characterization of arylhydrazones of active methylene derivatives
title_full In vitro characterization of arylhydrazones of active methylene derivatives
title_fullStr In vitro characterization of arylhydrazones of active methylene derivatives
title_full_unstemmed In vitro characterization of arylhydrazones of active methylene derivatives
title_short In vitro characterization of arylhydrazones of active methylene derivatives
title_sort in vitro characterization of arylhydrazones of active methylene derivatives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856940/
https://www.ncbi.nlm.nih.gov/pubmed/29556135
http://dx.doi.org/10.1016/j.jsps.2017.12.018
work_keys_str_mv AT palanivelsuresh invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT zhurinaanastasia invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT doanphuong invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT chandraseelanjeromeg invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT khandelwalvinothkumarmegraj invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT zubkovfedori invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT mahmudovkamrant invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT pombeiroarmandojl invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT yliharjaolli invitrocharacterizationofarylhydrazonesofactivemethylenederivatives
AT kandhavelumeenakshisundaram invitrocharacterizationofarylhydrazonesofactivemethylenederivatives